Literature DB >> 16026646

Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response.

Valentina Zuco1, Chiara Zanchi, Cinzia Lanzi, Giovanni L Beretta, Rosanna Supino, Claudio Pisano, Marcella Barbarino, Romina Zanier, Federica Bucci, Concetta Aulicino, Paolo Carminati, Franco Zunino.   

Abstract

Atypical retinoids are potent inducers of apoptosis, but activation of the apoptotic pathway seems to be independent of retinoid receptors. Previous studies with a novel adamantyl retinoid, ST1926, have shown that apoptosis induction is associated with an early genotoxic stress. To better understand the relevance of these events, we have selected a subline of the H460 lung carcinoma cell line resistant to ST1926. Resistant cells exhibited cross-resistance to a related molecule, CD437, but not cross-resistance to agents with different mechanisms of action. In spite of a lack of defects in intracellular drug accumulation, induction of DNA strand breaks in resistant cells required exposure to a substantially higher concentration, which was consistent with the degree of resistance. At drug concentrations causing a similar antiproliferative effect (IC80) and a comparable extent of DNA lesions in sensitive and resistant cells, the apoptotic response was a delayed and less marked event in resistant cells, thus indicating a reduced susceptibility to apoptosis. In spite of recognition of DNA lesions in resistant cells, as supported by phosphorylation of p53 and histone H2AX, resistant cells exhibited no activation of the mitochondrial pathways of apoptosis. Following exposure to equitoxic drug concentrations, only sensitive cells exhibited a typical stress/DNA damage response, with activation of the S-phase checkpoint. The cellular resistance to ST1926 reflects alterations responsible for a reduced generation of DNA lesions and for an enhanced tolerance of the genotoxic stress, resulting in lack of activation of the intrinsic pathway of apoptosis. The defective DNA damage response, accompanied by a reduced susceptibility to apoptosis in resistant cells, provides further support to the involvement of genotoxic stress as a critical event in mediating apoptosis induction by ST1926.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026646      PMCID: PMC1501428          DOI: 10.1593/neo.05127

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  35 in total

Review 1.  DNA repair: spot(light)s on chromatin.

Authors:  M Modesti; R Kanaar
Journal:  Curr Biol       Date:  2001-03-20       Impact factor: 10.834

Review 2.  Mitochondrion as a novel target of anticancer chemotherapy.

Authors:  P Costantini; E Jacotot; D Decaudin; G Kroemer
Journal:  J Natl Cancer Inst       Date:  2000-07-05       Impact factor: 13.506

3.  Apoptosis. Mitochondria--the death signal integrators.

Authors:  C Brenner; G Kroemer
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

4.  Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid.

Authors:  V Zuco; C Zanchi; G Cassinelli; C Lanzi; R Supino; C Pisano; R Zanier; V Giordano; E Garattini; F Zunino
Journal:  Cell Death Differ       Date:  2004-03       Impact factor: 15.828

5.  Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells.

Authors:  S Y Sun; P Yue; R Lotan
Journal:  Oncogene       Date:  2000-09-14       Impact factor: 9.867

Review 6.  Retinoid targets for apoptosis induction.

Authors:  Magnus Pfahl; Francisco Javier Piedrafita
Journal:  Oncogene       Date:  2003-12-08       Impact factor: 9.867

7.  Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy.

Authors:  Neelam Taneja; Mandel Davis; John S Choy; Michael A Beckett; Rachana Singh; Stephen J Kron; Ralph R Weichselbaum
Journal:  J Biol Chem       Date:  2003-10-15       Impact factor: 5.157

8.  Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway.

Authors:  William F Holmes; Dianne Robert Soprano; Kenneth J Soprano
Journal:  Oncogene       Date:  2003-09-25       Impact factor: 9.867

9.  DNA damage induced by DNA topoisomerase I- and topoisomerase II-inhibitors detected by histone H2AX phosphorylation in relation to the cell cycle phase and apoptosis.

Authors:  Xuan Huang; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2003 Nov-Dec       Impact factor: 4.534

10.  ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis.

Authors:  Enrico Garattini; Edoardo Parrella; Luisa Diomede; Maurizio Gianni'; Yesim Kalac; Lucio Merlini; Daniele Simoni; Romina Zanier; Fabiana Fosca Ferrara; Ilaria Chiarucci; Paolo Carminati; Mineko Terao; Claudio Pisano
Journal:  Blood       Date:  2003-09-04       Impact factor: 22.113

View more
  8 in total

Review 1.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

Review 2.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

3.  Insights into the binding mode and mechanism of action of some atypical retinoids as ligands of the small heterodimer partner (SHP).

Authors:  Marco Cellanetti; Viswanath Gunda; Li Wang; Antonio Macchiarulo; Roberto Pellicciari
Journal:  J Comput Aided Mol Des       Date:  2010-09-30       Impact factor: 3.686

4.  Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78.

Authors:  Jui-Ling Hsu; Po-Cheng Chiang; Jih-Hwa Guh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11       Impact factor: 3.000

5.  Cyclic pifithrin-alpha sensitizes wild type p53 tumor cells to antimicrotubule agent-induced apoptosis.

Authors:  Valentina Zuco; Franco Zunino
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

6.  Mechanism of action of the atypical retinoid ST1926 in colorectal cancer: DNA damage and DNA polymerase α.

Authors:  Rana Abdel-Samad; Patrick Aouad; Hala Gali-Muhtasib; Zeinab Sweidan; Raed Hmadi; Humam Kadara; Egildo Luca D'Andrea; Alessandra Fucci; Claudio Pisano; Nadine Darwiche
Journal:  Am J Cancer Res       Date:  2018-01-01       Impact factor: 6.166

7.  Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo.

Authors:  Valentina Zuco; Michelandrea De Cesare; Raffaella Cincinelli; Raffaella Nannei; Claudio Pisano; Nadia Zaffaroni; Franco Zunino
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

8.  Augmented Therapeutic Potential of EC-Synthetic Retinoids in Caco-2 Cancer Cells Using an In Vitro Approach.

Authors:  Mohamed R Abdelaal; Esraa Ibrahim; Mohamed R Elnagar; Sameh H Soror; Hesham Haffez
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.